BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19131781)

  • 1. IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report.
    Galeotti C; Tran TA; Franchi-Abella S; Fabre M; Pariente D; Koné-Paut I
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):920-4. PubMed ID: 19131781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed variant multicentric Castleman disease treated with rituximab: case report.
    Mian H; Leber B
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):622. PubMed ID: 20921905
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
    Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
    Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
    Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC
    WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unicentric Castleman disease relapsed after rituximab-CHOP chemotherapy or radiation therapy in an adolescent.
    Baek HJ; Kook H; Han DK; Shin MG; Kim HS; Hwang TJ
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):e206-8. PubMed ID: 22258344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
    Ocio EM; Sanchez-Guijo FM; Diez-Campelo M; Castilla C; Blanco OJ; Caballero D; San Miguel JF
    Am J Hematol; 2005 Apr; 78(4):302-5. PubMed ID: 15795923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
    Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
    Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist.
    Stenerson M; Dufendach K; Aksentijevich I; Brady J; Austin J; Reed AM
    Arthritis Rheum; 2011 Dec; 63(12):4018-22. PubMed ID: 21792839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Is the best treatment for HIV-associated multicentric Castleman disease?
    Bower M; Dalla Pria A
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
    Peker D; Martinez AE; Schwartz MA; Cusnir M
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome.
    Ganti AK; Pipinos I; Culcea E; Armitage JO; Tarantolo S
    Am J Hematol; 2005 Jul; 79(3):206-10. PubMed ID: 15981232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentric Castleman disease presenting with fever.
    Smith C; Lee-Miller C; Dishop MK; Cost C; Wang M; Asturias EJ
    J Pediatr; 2014 Dec; 165(6):1261-5. PubMed ID: 25282064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
    Ide M; Kawachi Y; Izumi Y; Kasagi K; Ogino T
    Eur J Haematol; 2006 Feb; 76(2):119-23. PubMed ID: 16405432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schnitzler syndrome: response to anakinra in two cases and a review of the literature.
    Schuster C; Kränke B; Aberer E; Arbab E; Sturm G; Aberer W
    Int J Dermatol; 2009 Nov; 48(11):1190-4. PubMed ID: 20064173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentric Castleman's disease & HIV infection.
    Cotter A; Lambert J; O'Gorman P
    Ir Med J; 2009 Oct; 102(9):294-5. PubMed ID: 19902650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Schnitzler syndrome: case report, the experience with glucocorticoid and anakinra (Kineret) therapies and monitoring of systemic cytokine response].
    Szturz P; Adam Z; Klabusay M; Fojtík Z; Kadanka Z; Stehlíková O; Chovancová J; Kalvodová L; Corbová D; Starý K; Neubauer J; Prásek J; Koukalová R; Rehák Z; Hájek R; Mayer J
    Vnitr Lek; 2011 Jan; 57(1):97-112. PubMed ID: 21351669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized abdominal Castleman disease masquerading as malabsorption syndrome.
    Sari S; Okur A; Yeşilkaya E; Dalgiç B; Karadeniz C; Oğuz A; Gürsel T; Sönmez K; Gönül II
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):618-20. PubMed ID: 18799941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.